Pluristem Therapeutics Inc.
PSTI · NASDAQ
6/30/2025 | 6/30/2021 | 6/30/2020 | 6/30/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $6 | $31 | $8 | $4 |
| Short-Term Investments | $0 | $34 | $38 | $20 |
| Receivables | $0 | $1 | $2 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $16 | $1 | $1 | $1 |
| Total Curr. Assets | $22 | $67 | $48 | $26 |
| Property Plant & Equip (Net) | $9 | $2 | $0 | $0 |
| Goodwill | $3 | $0 | $0 | $0 |
| Intangibles | $3 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | -$20 | $24 | $17 | $5 |
| Total NC Assets | -$6 | $26 | $17 | $5 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $17 | $94 | $66 | $31 |
| Liabilities | – | – | – | – |
| Payables | $1 | $3 | $2 | $2 |
| Short-Term Debt | $1 | $1 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $30 | $8 | $6 | $6 |
| Total Curr. Liab. | $32 | $12 | $8 | $8 |
| LT Debt | $6 | $24 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $1 | $1 | $1 |
| Total NC Liab. | $7 | $25 | $1 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $7 | $36 | $9 | $9 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$443 | -$330 | -$280 | -$251 |
| AOCI | $0 | $0 | -$15 | -$13 |
| Other Equity | $436 | $387 | $351 | $286 |
| Total Equity | -$7 | $57 | $56 | $22 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $6 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $0 | $94 | $66 | $31 |
| Net Debt | $1 | -$7 | -$8 | -$4 |